August 5, 2020
503B bulk: What’s in? What’s out? Who tells the story?
Racehorses, compounding and confusion
In recent weeks there’s been a persistent rumor that the governing body for horse-racing has banned compounded drugs because they are not FDA approved. But that’s not the case. read more →
Coming soon: Compounding certificate program for your new hires
Later this spring, we’ll be debuting a new 15-hour certificate program, “The Ethical, Legal, and Regulatory Framework of Pharmacy Compounding.” read more →
California BOP compounding proposals out of sync with national standards
The California Board of Pharmacy’s Enforcement and Compounding Committee met yesterday to discuss proposed regulations related to sterile compounding. read more →
March policy video: Here’s what’s happening
Check out the latest public policy update video from APC Director of Public Policy Savannah Cunningham, PharmD. read more →
GFI 256 enforcement starts April 1. Is your pharmacy ready? Our 3/22 webinar can help…
In advance of the April 1, 2023, enforcement date for the new animal compounding guidance from FDA, APC and PCCA are partnering to offer a CE webinar aimed at helping you bring your animal compounding operations into compliance. read more →
CVM issues Letter to Industry on GFI 256 phase-in
In response to a request from APC and NCPA, FDA’s Center for Veterinary Medicine last week issued a Letter to Industry explaining the phased-in approach to enforcement the agency plans to take on GFI 256. read more →
Explain yourself to prescribers
The Prescriber Briefs developed by APC and the Pharmacy Compounding Foundation are excellent resources for educating prescribers about pharmacy compounding—including laws, guidance, and standards you must adhere to. read more →
Extended: APC Fellows application date (now June 1)
Since the program’s inception, 112 pharmacists have been nominated to this elite group. Thirteen new members were inducted during last year's Compounders on Capitol Hill. read more →
OPEN TO ALL COMPOUNDERS: GFI 256 compliance webinar
In advance of the Apr 1, 2023, enforcement date for the new animal compounding guidance from FDA, APC and PCCA are partnering to offer a CE webinar aimed at helping you bring your animal compounding operations into compliance. read more →
August 5, 2020
Finally! Guess what, 503B pharmacies? The FDA is — after half a decade — considering updating the bulk drug substances list, and it wants your input.
IN (proposed): DPCP, glycolic acid, SADBE, TCA — see https://www.federalregister.gov/d/2020-16649/p-58
OUT (proposed): 19 other substances — see https://www.federalregister.gov/d/2020-16649/p-78
Where to comment: https://beta.regulations.gov/comment/FDA-2018-N-3240-0054
CONTACT US
E-mail: info@a4pc.org
Phone: (281) 933-8400
Fax: (281) 495-0602
Mailing: Alliance for Pharmacy Compounding
100 Daingerfield Road, Ste. 100
Alexandria, VA 22314
APC is committed to addressing any concerns or complaints within one business day. Please send them — and, of course, any compliments — to info@a4pc.org.
THE APC FAMILY